Biocept, Inc.
Biocept, Inc., a leading molecular diagnostics company headquartered in the United States, specialises in the development of innovative liquid biopsy technologies. Founded in 2011, Biocept has made significant strides in the oncology sector, focusing on the detection and monitoring of cancer through its proprietary assays. The company’s core offerings include its advanced circulating tumour cell (CTC) and circulating tumour DNA (ctDNA) tests, which provide critical insights for personalised cancer treatment. Biocept's unique approach to liquid biopsies sets it apart in the competitive landscape, enabling non-invasive testing that enhances patient care. With a strong market position, Biocept has achieved notable milestones, including partnerships with major healthcare institutions and a growing portfolio of intellectual property. As it continues to expand its operational reach, Biocept remains committed to advancing cancer diagnostics and improving patient outcomes.
DitchCarbon Score
How does Biocept, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biocept, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biocept, Inc.'s reported carbon emissions
Biocept, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Biocept may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the broader industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, Biocept's position in this regard remains unclear. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its sustainability profile and align it with industry best practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biocept, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
